Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2003-10-01 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BIARRITZ (64200), Pyrenees-Atlantiques
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BIARRITZ IRATY : revenue, balance sheet and financial ratios
PHARMACIE BIARRITZ IRATY is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BIARRITZ (64200),
this company of category PME
shows in 2016 a revenue of 999 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BIARRITZ IRATY (SIREN 453542771)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
998 969 €
Net income
22 272 €
-25 274 €
24 056 €
-24 056 €
164 050 €
0 €
-128 234 €
1 112 €
-227 504 €
8 340 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
29 640 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
0.8%
Revenue and income statement
In 2025, PHARMACIE BIARRITZ IRATY generates positive net income of 22 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 8 k€ -> 22 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
22 272 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 168%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
168.469%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
31.762%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
156.678
304.08
329.681
476.601
468.463
240.102
207.581
215.293
180.214
168.469
Financial autonomy
34.944
22.899
21.523
15.221
15.035
25.314
27.64
26.815
29.529
31.762
Repayment capacity
86.935
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
0.961%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
168.472025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of PHARMACIE BIARRITZ IRATY (168.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
31.76%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE BIARRITZ IRATY (31.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 177.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
147.984
160.944
228.079
146.779
185.122
257.015
189.691
242.127
156.541
176.999
Interest coverage
108.667
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
177.02025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-19 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BIARRITZ IRATY (177.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 5 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 287 days. Excellent situation: suppliers finance 282 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
5 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
287 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BIARRITZ IRATY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
287 703 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
51
0
0
0
0
0
0
0
0
0
Customer payment term (days)
2
0
0
13
0
0
0
0
0
5
Supplier payment term (days)
32
0
0
554
0
0
0
0
0
287
Positioning of PHARMACIE BIARRITZ IRATY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BIARRITZ IRATY is estimated at
353 793 €
(range 240 085€ - 555 150€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
240k€353k€555k€
353 793 €Range: 240 085€ - 555 150€
NAF 5 année 2025
Valuation method used
Net Income Multiple
22 272 €
×
15.9x
=353 793 €
Range: 240 086€ - 555 151€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BIARRITZ IRATY with other companies in the same sector:
Frequently asked questions about PHARMACIE BIARRITZ IRATY
What is the revenue of PHARMACIE BIARRITZ IRATY ?
The revenue of PHARMACIE BIARRITZ IRATY in 2016 is 999 k€.
Is PHARMACIE BIARRITZ IRATY profitable?
Yes, PHARMACIE BIARRITZ IRATY generated a net profit of 22 k€ in 2025.
Where is the headquarters of PHARMACIE BIARRITZ IRATY ?
The headquarters of PHARMACIE BIARRITZ IRATY is located in BIARRITZ (64200), in the department Pyrenees-Atlantiques.
Where to find the tax return of PHARMACIE BIARRITZ IRATY ?
The tax return of PHARMACIE BIARRITZ IRATY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BIARRITZ IRATY operate?
PHARMACIE BIARRITZ IRATY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart